|
|
CustomVue Technology
Treat More Patients
The VISX CustomVue procedure now provides the
broadest range of U.S. FDA approved wavefront-guided
laser vision correction treatments for your patients including:
- Myopia with and without Astigmatism
- Hyperopia with and without Astigmatism
As shown in FDA clinical studies, the CustomVue procedure may improve vision beyond the correction possible with contact lenses or glasses.
Treatment Parameters Approved by U.S. FDA
Treatment |
Refractive Error |
Approved Range |
The VISX STAR S4 IR Excimer Laser System and the WaveScan WaveFront System are approved by the U.S. FDA for: |
CustomVue Wavefront-Guided LASIK |
Low to Moderate Myopia |
Up to -6.0 D MRSE with or without astigmatism up to -3.0 DC |
High Myopia |
From -6.0 D to -11.0 D MRSE , with or without astigmatism up to -3.0 DC |
Hyperopia |
Up to +3.0 D MRSE with or without astigmatism up to +2.0 DC |
Mixed Astigmatism |
From 1.0 D to 5.0 DC, cylinder > sphere and of opposite sign |
The VISX STAR S4 IR Excimer Laser System is approved by the U.S. FDA for: |
LASIK |
Myopia |
Up to -14.0 DS with or without astigmatism -0.5 to -5.0 DC |
Hyperopia |
+0.5 to +5.0 DS with or without astigmatism up to +3 DC |
Mixed Astigmatism |
Up to 6.0 DC, cylinder > sphere and of opposite sign |
PRK |
Myopia |
0 to -12.0 DS, with or without astigmatism -0.75 to -4.0 DC |
Hyperopia |
+1.0 to +6.0 DS, with or without astigmatism +0.5 to +4.0 DC |
PTK |
N/A (Therapeutic) |
Therapeutic/non-refractive treatments. Contact VISX for details. |
Custom-CAP |
N/A (Therapeutic) |
Topography-driven therapeutic treatments. Contact VISX for more information. |
Please review the important information contained in the Physician Information Sheet
|
|
|
